PORTLAND, Ore (KOIN) – On behalf of our sponsors at Abbott, we’re learning about how a medical breakthrough is transforming the way we treat abnormal heart rhythms and one Boston mother’s story shows ...
The FDA has approved Abbott Laboratories' ABT AVEIR dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacing system to treat abnormal or slow heart rhythms. Through ...
Having an accelerated junctional rhythm occurs when the atrioventricular node in your heart beats too quickly. It happens as a result of damage to your heart’s primary natural pacemaker. There’s no ...
Last week, Abbott began the commercial launch of its new leadless pacemaker, which it believes is a historic development in the world of cardiac rhythm devices. Aveir DR is a better option than ...
NICE recommends leadless cardiac pacemakers as the standard of care for people with slow heart rhythms. NICE has issued final guidance recommending leadless cardiac pacemakers as the standard of care ...
Four late-breaking presentations at Heart Rhythm Society 2026 in Chicago highlight strong clinical evidence across Abbott's growing pulsed field ablation and novel cardiac pacing portfolios Six-month ...
The heart may be small, but its rhythm powers life. When something throws that rhythm off—especially after surgery—it can become a race against time to restore balance. For decades, doctors have ...
ABBOTT PARK, Ill., Nov. 12, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced new, late-breaking data from the global Leadless II IDE study evaluating Abbott's investigational Aveir leadless ...
A doctor may recommend surgery for arrhythmia when medications and lifestyle changes haven’t been effective. The different types of arrhythmia surgeries each aim to restore a regular heart rhythm.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results